JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 36 No. 5 762-770
© 1995 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suga, K.
Right arrow Articles by Suzuki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suga, K.
Right arrow Articles by Suzuki, T.

Thallium-201 SPECT and Technetium-99m-Phytate Subtraction Liver Imaging in the Evaluation of Pancreatic Cancers

Kazuyoshi Suga, Kazuya Nishigauchi, Norihiko Kume, Takeshi Fujita, Takashi Nakanishi, Tatsunori Hamasaki and Takashi Suzuki

Departments of Radiology and Second Surgery, Yamaguchi University School of Medicine, Kogushi, Japan

Correspondence: For correspondence or reprints contact: Kazuyoshi Suga, Department of Radiology, Yamaguchi University School of Medicine, Kogushi 1144, Ube, Japan 755.

ABSTRACT

We preliminary evaluated the usefulness of 201Tl SPECT in the investigation of pancreatic cancers. Methods: The subjects included 32 patients with malignant tumors, 16 with benign disorders and 10 controls. SPECT was performed 10 min after the injection of 148–222 MBq of 201Tl; subjects had fasted to minimize intestinal activity. In addition, subtracted SPECT using 99mTc-phytate to separate the boundary of abnormal uptake from liver activity was carried out in 14 patients. Results: Thallium-201 did not accumulate in the pancreatic bed of the controls. In contrast, 29 of the 32 patients with malignant tumors showed positive phytate uptake with a sensitivity of 90.6% in the detection of malignancy. Of the 16 benign disorders, only four patients showed abnormal uptake; however, the mean value of the lesion-to-hepatic ratio (0.43 ± 0.06; range, 0.35–0.51), as an index of the degree of uptake, was lower than that in positive malignant tumors (0.72 ± 0.16; range, 0.53–1.28). Thallium-201 activity per milligram of resected cancer tissue in two patients was 2–3 times greater than in normal tissue. Follow-up 201Tl SPECT in the five treated patients demonstrated similar alterations between 201Tl uptake and tumor markers. Conclusion: Our results suggest that 201Tl SPECT may have clinical potential in the investigation of pancreatic cancers.

Key Words: thallium-201-chloride • pancreatic cancer • chronic pancreatitis • single-photon emission computed tomography • technetium-99m-phytate







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1995 by the Society of Nuclear Medicine.